On Dec. 20, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved BRAFTOVI® (encorafenib)…
On Dec. 18, 2024, the Barbara Ann Karmanos Cancer Institute announced that the new TheraBionic P1 device, an…
On Dec. 12, 2024, a study co-lead by researchers from the University of British Columbia, Vancouver General Hospital…
On Dec. 4, 2024, The U.S. Food and Drug Administration (FDA) announced approved of AstraZeneca’s blockbuster drug Imfinzi…
On Dec. 4, 2024, researchers at the Centre for Genomic Regulation (CRG) in Barcelona announced they had discovered…
On Nov. 20, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
On Nov. 12, 2024, a research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that…
On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
On Nov. 6, 2024, a trio of new studies with funding from Cancer Grand Challenges revealed the unfair advantage…
On Nov. 5, 2024, a cross-sectional study of data for 36 cancer types from 185 countries and territories…
On Oct. 29, 2024, a study led by Andrei Gudkov, PhD, DSci, at Roswell Park Comprehensive Cancer Center support…
On Oct. 29, 2024, a study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center (UCLA…
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
On Oct. 4, 2024, the World Health Organization (WHO) announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine…
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
On Oct. 2, 2024, a study from the GBD Tobacco Forecasting Collaborators reported that by accelerating the decline…
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
On Sep. 4, 2024, an international consortium led by scientists from Uppsala University in Sweden reported that the…
On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
On Aug. 29, 2024, researchers at the Garvan Institute of Medical Research announced they had mapped 50,000 of…
On Aug. 23, 2024, A team of researchers from the University of Cologne announced they had created a…
On Aug. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Aug. 15, 2024, a study published in the journal Cancer projected an alarming increase in cancer cases and deaths…
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…